In this episode, Colleen Kelley, MD, MPH, discusseskey features and available safety and efficacy data on investigational long-acting HIV pre-exposure prophylaxis strategies that are in late stages of clinical development.
Presenter:
Colleen Kelley, MD, MPH
Atlanta, Georgia
Colleen Kelley, MD, MPH, has disclosed that she has received funds for research support from Gilead Sciences, Moderna, Novavax, and ViiV Healthcare.
Content based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.
Link to full program: https://bit.ly/3AFvsZY
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
